BioMarin Pharmaceutical, Inc. (BMRN)
64.68
-0.40
(-0.61%)
USD |
NASDAQ |
Sep 18, 14:17
BioMarin Pharmaceutical 30-Day Average Daily Volume : 2.156M for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 2.156M |
| September 16, 2026 | 2.166M |
| September 15, 2026 | 2.133M |
| September 14, 2026 | 2.132M |
| September 11, 2026 | 2.167M |
| September 10, 2026 | 2.154M |
| September 09, 2026 | 2.141M |
| September 08, 2026 | 2.141M |
| September 04, 2026 | 2.147M |
| September 03, 2026 | 2.135M |
| September 02, 2026 | 2.169M |
| September 01, 2026 | 2.132M |
| August 31, 2026 | 2.127M |
| August 28, 2026 | 2.090M |
| August 27, 2026 | 2.107M |
| August 26, 2026 | 2.108M |
| August 25, 2026 | 2.076M |
| August 24, 2026 | 2.077M |
| August 21, 2026 | 2.054M |
| August 20, 2026 | 2.053M |
| August 19, 2026 | 2.042M |
| August 18, 2026 | 2.028M |
| August 17, 2026 | 2.016M |
| August 14, 2026 | 2.001M |
| August 13, 2026 | 2.004M |
| Date | Value |
|---|---|
| August 12, 2026 | 1.976M |
| August 11, 2026 | 1.938M |
| August 10, 2026 | 1.866M |
| August 07, 2026 | 1.822M |
| August 06, 2026 | 1.766M |
| August 05, 2026 | 1.704M |
| August 04, 2026 | 1.716M |
| August 03, 2026 | 1.775M |
| July 31, 2026 | 1.829M |
| July 30, 2026 | 1.808M |
| July 29, 2026 | 1.818M |
| July 28, 2026 | 1.807M |
| July 27, 2026 | 1.778M |
| July 24, 2026 | 1.778M |
| July 23, 2026 | 1.782M |
| July 22, 2026 | 1.790M |
| July 21, 2026 | 1.812M |
| July 20, 2026 | 1.832M |
| July 17, 2026 | 1.862M |
| July 16, 2026 | 1.884M |
| July 15, 2026 | 1.931M |
| July 14, 2026 | 1.995M |
| July 13, 2026 | 2.130M |
| July 10, 2026 | 2.138M |
| July 09, 2026 | 2.164M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.644M |
| Vertex Pharmaceuticals, Inc. | 1.044M |
| BridgeBio Pharma, Inc. | 2.212M |
| Incyte Corp. | 1.312M |
| Ionis Pharmaceuticals, Inc. | 3.082M |